Metastasis suppressors genes in cancer.
暂无分享,去创建一个
[1] P. Steeg. Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.
[2] Victoria Bolós,et al. Notch signaling in development and cancer. , 2007, Endocrine reviews.
[3] T. Mashimo,et al. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. , 2000, Biochemical and biophysical research communications.
[4] B. Weissman,et al. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. , 1996, Cancer research.
[5] R. Khokha. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. , 1994, Journal of the National Cancer Institute.
[6] V. Robinson,et al. MKK4 and metastasis suppression: A marriage of signal transduction and metastasis research , 2004, Clinical & Experimental Metastasis.
[7] S. Thorgeirsson,et al. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. , 1998, Cancer research.
[8] D. Welch,et al. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. , 2006, Biochemical and biophysical research communications.
[9] R. Biondi,et al. Inhibition of nucleoside diphosphate kinase activity by in vitro phosphorylation by protein kinase CK2 Differential phosphorylation of NDP kinases in HeLa cells in culture , 1996, FEBS letters.
[10] E. Ruoslahti. Specialization of tumour vasculature , 2002, Nature Reviews Cancer.
[11] G. Bevilacqua,et al. High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis , 2007, International journal of cancer.
[12] P. Steeg,et al. Nm23/Nucleoside Diphosphate Kinase in Human Cancers , 2000, Journal of bioenergetics and biomembranes.
[13] B. O'dowd,et al. Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation , 2001, The Journal of cell biology.
[14] P. Kleihues,et al. Loss of DCC expression and glioma progression. , 1997, Cancer research.
[15] B. Su,et al. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. , 2006, Cancer research.
[16] G. Casey,et al. Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-κB Activity , 2005 .
[17] Chrisostomos Prodromou,et al. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)‐domain co‐chaperones , 1999, The EMBO journal.
[18] K. Pacak,et al. Downregulation of metastasis suppressor genes in malignant pheochromocytoma , 2005, International journal of cancer.
[19] E. Odintsova,et al. Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR , 2003, Journal of Cell Science.
[20] J E Talmadge,et al. Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.
[21] J. Keaney,et al. EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis. , 2005, American journal of physiology. Heart and circulatory physiology.
[22] P. Meltzer,et al. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. , 2007, Cancer research.
[23] D. Welch,et al. Breast cancer metastasis suppressor 1: Update , 2004, Clinical & Experimental Metastasis.
[24] S. Thorgeirsson,et al. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells , 2004, Oncogene.
[25] D. Welch,et al. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. , 2001, Cancer research.
[26] Kedar S Vaidya,et al. Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells. , 2009, Cancer letters.
[27] Yong Pan,et al. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors , 2004, Oncogene.
[28] D. Morrison,et al. Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway* , 2002, The Journal of Biological Chemistry.
[29] K. Arden,et al. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. , 2002, Cancer research.
[30] C. Miranti,et al. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases , 2006, Oncogene.
[31] A. Logan,et al. Angiogenesis , 1993, The Lancet.
[32] Gabriele Schackert,et al. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. , 2007, Carcinogenesis.
[33] P. Jackson,et al. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. , 2004, Cancer letters.
[34] W. Cole,et al. Technique and results of isolation of cancer cells from the circulating blood. , 1958, A.M.A. archives of surgery.
[35] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[36] J. Hamada,et al. Gelsolin functions as a metasatsis suppressor in B16‐BL6 mouse melanoma cells and requirement of the carboxyl‐terminus for its effect , 2001, International journal of cancer.
[37] W. Weis,et al. Re-solving the Cadherin-Catenin-Actin Conundrum* , 2006, Journal of Biological Chemistry.
[38] F. Berditchevski,et al. Function of α3β1–Tetraspanin Protein Complexes in Tumor Cell Invasion. Evidence for the Role of the Complexes in Production of Matrix Metalloproteinase 2 (Mmp-2) , 1999, The Journal of cell biology.
[39] P. Herrlich,et al. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. , 1993, Cancer research.
[40] J. Barrett,et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.
[41] M. Hemler. Tetraspanin functions and associated microdomains , 2005, Nature Reviews Molecular Cell Biology.
[42] C. Underhill,et al. CD44: the hyaluronan receptor. , 1992, Journal of cell science.
[43] N. Shimada,et al. Evidence for complex formation between GTP binding protein(Gs) and membrane-associated nucleoside diphosphate kinase. , 1990, Biochemical and biophysical research communications.
[44] K. Kim,et al. KAI1 COOH-Terminal Interacting Tetraspanin (KITENIN), a Member of the Tetraspanin Family, Interacts with KAI1, a Tumor Metastasis Suppressor, and Enhances Metastasis of Cancer , 2004, Cancer Research.
[45] Lei Liu,et al. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. , 2003, Cancer research.
[46] J. Bravo,et al. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. , 2007, Journal of proteome research.
[47] D. Welch,et al. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. , 2000, Cancer research.
[48] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[49] Bin Zhou,et al. The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity , 2004, Cancer Research.
[50] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[51] M. Rosner,et al. Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation* , 2005, Journal of Biological Chemistry.
[52] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[53] C. Moskaluk,et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. , 2002, Cancer research.
[54] A. Iizuka,et al. Induction of KAI-1 expression in metastatic cancer cells by phorbol esters. , 2000, Cancer letters.
[55] P. Waterhouse,et al. Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. , 1992, Journal of the National Cancer Institute.
[56] A. Montag,et al. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. , 2002, Cancer research.
[57] Ying Jiang,et al. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. , 2007, Journal of the National Cancer Institute.
[58] H. Frierson,et al. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia , 2007, Oncogene.
[59] M. Yáñez-Mó,et al. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. , 2001, Blood.
[60] O. Nishimura,et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.
[61] S. Thorgeirsson,et al. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity , 2003, Oncogene.
[62] L. Freedman,et al. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. , 2003, Cancer research.
[63] S. Goodison,et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. , 2005, Cancer research.
[64] D. Boyd,et al. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. , 2001, The Journal of biological chemistry.
[65] K Satyamoorthy,et al. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.
[66] B. Weimer,et al. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression , 2007, Clinical & Experimental Metastasis.
[67] Nils Cordes,et al. Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.
[68] D. Welch. Do we need to redefine a cancer metastasis and staging definitions? , 2006, Breast disease.
[69] R. Davis,et al. Role of mitogen-activated protein kinase kinase 4 in cancer , 2007, Oncogene.
[70] C. López-Otín,et al. Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.
[71] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[72] J. Figge,et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma: Correlation with tumor grade and ploidy , 1996, Cancer.
[73] M. Oshimura,et al. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. , 1992, Cancer research.
[74] Alicia Zhou,et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.
[75] M. Cristofanilli,et al. Manipulating the chemokine‐chemokine receptor network to treat cancer , 2007, Cancer.
[76] Xiu-fen Lei,et al. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. , 2006, Cancer research.
[77] C. Kahn,et al. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. , 2001, Cancer research.
[78] L. Liotta,et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.
[79] Karin Oien,et al. Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis , 2005, Clinical Cancer Research.
[80] C. D. dos Remedios,et al. Actin binding proteins: regulation of cytoskeletal microfilaments. , 2003, Physiological reviews.
[81] W. Ellis,et al. Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[82] H. Aburatani,et al. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo , 2003, International journal of cancer.
[83] M. Toyota,et al. Epigenetic Regulation of the KAI1 Metastasis Suppressor Gene in Human Prostate Cancer Cell Lines , 2001, Japanese journal of cancer research : Gann.
[84] Y. Okada,et al. TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.
[85] D. Lambeth,et al. The Human Nm23/Nucleoside Diphosphate Kinases , 2000, Journal of bioenergetics and biomembranes.
[86] Hee June Choi,et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes , 2005, Nature.
[87] K. Tanaka,et al. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. , 1992, Cancer research.
[88] C. Sheehan,et al. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. , 2004, Annals of diagnostic pathology.
[89] S. Eccles,et al. Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.
[90] I. Hilgert,et al. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins , 2004, Immunogenetics.
[91] Hyun Seok Song,et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.
[92] J. Barrett,et al. Loss of KAI1 expression in the progression of colorectal cancer. , 1999, Cancer research.
[93] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[94] Jeffrey W. Clark,et al. Lessons from phase III clinical trials on anti-VEGF therapy for cancer , 2006, Nature Clinical Practice Oncology.
[95] S. Steinberg,et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. , 2005, Journal of the National Cancer Institute.
[96] C. Boucheix,et al. CD19 Is Linked to the Integrin-associated Tetraspans CD9, CD81, and CD82* , 1998, The Journal of Biological Chemistry.
[97] J. Vassy,et al. Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit. , 1999, Experimental cell research.
[98] K. Miura,et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.
[99] A. Alessandrini,et al. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. , 2002, Experimental cell research.
[100] P. Waterhouse,et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. , 1989, Science.
[101] The KISS1 metastasis suppressor: mechanistic insights and clinical utility. , 2006, Frontiers in bioscience : a journal and virtual library.
[102] Deqin Ma,et al. Potential roles of 3′-5′exonuclease activity of NM23-H1 in DNA repair and malignant progression , 2006, Journal of bioenergetics and biomembranes.
[103] P. Friedl,et al. Collective cell migration in morphogenesis and cancer. , 2004, The International journal of developmental biology.
[104] G. Casey,et al. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells , 2004, Clinical & Experimental Metastasis.
[105] Kedar S Vaidya,et al. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. , 2007, Journal of the National Cancer Institute.
[106] M. Yamazaki,et al. Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes. , 1985, Japanese journal of cancer research : Gann.
[107] L. Liotta,et al. A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase , 1990, Cell.
[108] I. Gelman,et al. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein. , 2002, Experimental cell research.
[109] C. Welter,et al. Glyceraldehyde-3-phosphate Dehydrogenase and Nm23-H1/Nucleoside Diphosphate Kinase A , 1998, The Journal of Biological Chemistry.
[110] J. Becker,et al. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. , 2003, Cancer research.
[111] R. Silverman,et al. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[112] Dan Theodorescu,et al. Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer , 2004, Clinical Cancer Research.
[113] J. Szöllősi,et al. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. , 1996, Journal of immunology.
[114] G. Casey,et al. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation , 2007, Molecular Cancer.
[115] M. Hung,et al. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. , 2001, The American journal of pathology.
[116] Deqin Ma,et al. The Metastasis Suppressor NM23-H1 Possesses 3′-5′ Exonuclease Activity* , 2004, Journal of Biological Chemistry.
[117] J. Barrett,et al. Correlation between reduction of metastasis in the MDA‐MB‐435 model system and increased expression of the Kai‐1 protein , 1998, Molecular carcinogenesis.
[118] 三宅 智. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis , 1995 .
[119] T. Koyanagi,et al. Gelsolin: a candidate for suppressor of human bladder cancer. , 1995, Cancer research.
[120] A. Al-Mehdi,et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.
[121] P. Houghton,et al. Potentiation of neuroblastoma metastasis by loss of caspase-8 , 2006, Nature.
[122] S. Aaronson,et al. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.
[123] S. Brewster,et al. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. , 1994, The Journal of urology.
[124] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[125] R. Samant. Breast Cancer Metastasis-Suppressor 1 , 2008, Definitions.
[126] Wim H. M. Saris,et al. Proceedings of the American Association for Cancer Research. , 2001 .
[127] E. Bruyneel,et al. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis , 2007, Oncogene.
[128] Y. DeClerck,et al. Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)* , 1998, The Journal of Biological Chemistry.
[129] P. Steeg,et al. Site-directed Mutation of Nm23-H1 , 1997, The Journal of Biological Chemistry.
[130] M. Popoff,et al. Rho GTPases link cytoskeletal rearrangements and activation processes induced via the tetraspanin CD82 in T lymphocytes. , 2002, Journal of cell science.
[131] I. Fidler,et al. Genetic control of cancer metastasis. , 1990, Journal of the National Cancer Institute.
[132] C J Rhodes,et al. Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[133] H. Ford,et al. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.
[134] N. Christensen,et al. Analysis of mechanisms underlying BRMS1 suppression of metastasis , 2004, Clinical & Experimental Metastasis.
[135] G. Sonenshein,et al. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. , 2007, Cancer research.
[136] D. Stupack,et al. Does integrin-mediated cell death confer tissue tropism in metastasis? , 2006, Cancer research.
[137] Gillian Murphy,et al. The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.
[138] E. Robertson,et al. Regulation of Matrix Metalloproteinase 9 Expression by Epstein-Barr Virus Nuclear Antigen 3C and the Suppressor of Metastasis Nm23-H1 , 2005, Journal of Virology.
[139] M. Fukayama,et al. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential , 1994, Cancer.
[140] Joseph C. Shope,et al. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. , 2005, Cancer research.
[141] C. Chitnis,et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.
[142] B. Weissman,et al. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. , 1994, Oncogene.
[143] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[144] D. Theodorescu,et al. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines , 2004, Clinical & Experimental Metastasis.
[145] H. Mehdorn,et al. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases , 2005, Journal of Cancer Research and Clinical Oncology.
[146] G. Casey,et al. Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435 , 2006, Clinical & Experimental Metastasis.
[147] D. Huo,et al. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. , 2006, Cancer research.
[148] O. Witte,et al. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[149] R. Poulsom,et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.
[150] M. Murakami,et al. Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. , 2003, International immunology.
[151] M. Hung,et al. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. , 2000, Gynecologic oncology.
[152] Matthew J. Craig,et al. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases , 2007, Cancer and Metastasis Reviews.
[153] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[154] B. Aggarwal,et al. RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis* , 2004, Journal of Biological Chemistry.
[155] P. Steeg,et al. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines , 2004, Clinical & Experimental Metastasis.
[156] G. Bismuth,et al. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation , 2004, Journal of Cell Science.
[157] G. Bepler,et al. Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase. , 2006, Cancer research.
[158] B. Weissman,et al. KAI1, a putative marker for metastatic potential in human breast cancer. , 1997, Cancer letters.
[159] P. Steeg,et al. Inhibition of signal transduction by the nm23 metastasis suppressor: Possible mechanisms , 2004, Clinical & Experimental Metastasis.
[160] Kedar S Vaidya,et al. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.
[161] P. Steeg,et al. Nm23 and tumour metastasis: basic and translational advances. , 1998, Biochemical Society symposium.
[162] S. Hirohashi,et al. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma , 1993, International journal of cancer.
[163] H. Hamada,et al. Overexpression of CD82 on human T cells enhances LFA‐1 / ICAM‐1‐mediated cell‐cell adhesion: functional association between CD82 and LFA‐1 in T cell activation , 1999, European journal of immunology.
[164] Philip Smith,et al. Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis , 2006, Molecular and Cellular Biology.
[165] J. Workman,et al. Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription* , 2004, Journal of Biological Chemistry.
[166] M. Takata,et al. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. , 2001, Cancer research.
[167] F. Berditchevski,et al. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). , 1996, Journal of immunology.
[168] W. Stadler,et al. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. , 1999, Cancer research.
[169] H. Frierson,et al. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. , 2005, Cancer research.
[170] F. Huang,et al. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[171] Stuart A. Aaronson,et al. Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.
[172] John D. Potter,et al. Morphogens, morphostats, microarchitecture and malignancy , 2007, Nature Reviews Cancer.
[173] Loss of DCC expression in neuroblastoma is associated with disease dissemination. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[174] Arul M. Chinnaiyan,et al. Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells , 2006, Nucleic acids research.
[175] W. Dinjens,et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[176] D. Welch,et al. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate , 2004, Clinical & Experimental Metastasis.
[177] A. Lin,et al. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. , 2005, Cancer research.
[178] P. Jackson,et al. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells , 2005, Oncogene.
[179] Xu-wen Liu,et al. Novel functions of TIMPs in cell signaling , 2006, Cancer and Metastasis Reviews.
[180] G. Casey,et al. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. , 2005, Cancer research.
[181] Jing Qiao,et al. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[182] T. Toyama,et al. Reduced Expression of the Breast Cancer Metastasis Suppressor 1 mRNA Is Correlated with Poor Progress in Breast Cancer , 2006, Clinical Cancer Research.
[183] S. Thorgeirsson,et al. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas , 2004, Oncogene.
[184] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[185] F. Itoh,et al. Decreased expression of DCC mRNA in human colorectal cancers , 1993, International journal of cancer.
[186] D. Ross,et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma , 2007, Modern Pathology.
[187] P. Steeg,et al. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. , 1993, The Journal of biological chemistry.
[188] L. Matrisian,et al. Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications , 1999, Annals of the New York Academy of Sciences.
[189] P. Steeg,et al. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. , 1993, Cancer research.
[190] T. Choueiri,et al. Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients , 2006, Clinical Cancer Research.
[191] J. Risteli,et al. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[192] M. Kuwano,et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.